CAI; Suixiong

Patent Applications and Registrations

Patent applications and USPTO patent grants for CAI; Suixiong.The latest application filed is for "substituted fused heteroaromatic bicyclic compounds as kinase inhibitors and the use thereof".

Company Profile

6.11.14

CAI; Suixiong - Shanghai CN
Cai; Suixiong - Jaingsu CN
Cai; Suixiong - San Diego CA
Cai; Suixiong - Jiangsu N/A CN
Cai; Suixiong - Nanjing CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Fused Heteroaromatic Bicyclic Compounds As Kinase Inhibitors And The Use Thereof App 20220267332 - CAI; Suixiong ; et al.	2022-08-25
Imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-ones and the use thereof Grant 11,345,710 - Cai , et al. May 31, 2	2022-05-31
Solid Pharmaceutical Formulation of PARP Inhibitors and Use Thereof App 20220031702 - CAI; Suixiong ; et al.	2022-02-03
Solid pharmaceutical formulation of PARP inhibitors and use thereof Grant 11,179,392 - Cai , et al. November 23, 2	2021-11-23
Substituted Fused Heteroaromatic Tricyclic Compounds as Kinase Inhibitors and The Use Thereof App 20210128535 - CAI; Suixiong ; et al.	2021-05-06
Substituted fused heteroaromatic compounds as kinase inhibitors and the use thereof Grant 10,874,670 - Cai , et al. December 29, 2	2020-12-29
N-(3-heteroarylaryl)-4-arylarylcarboxamides and analogs as hedgehog pathway inhibitors and use thereof Grant 10,676,468 - Cai , et al.	2020-06-09
IMIDAZO[1,2-b]PYRIMIDO[4,5-d]PYRIDAZIN-5(6H)-ONES AND THE USE THEREOF App 20200131192 - CAI; Suixiong ; et al.	2020-04-30
Process for the preparation of 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones Grant 10,562,889 - Cai , et al. Feb	2020-02-18
Substituted Fused Heteroaromatic Compounds as Kinase Inhibitors and the Use Thereof App 20190358225 - CAI; Suixiong ; et al.	2019-11-28
Process For The Preparation Of 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones App 20190112298 - CAI; Suixiong ; et al.	2019-04-18
Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof Grant 10,149,841 - Zhou , et al. Dec	2018-12-11
Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparation method thereof and pharmaceutical use thereof Grant 10,100,051 - Zhou , et al. October 16, 2	2018-10-16
Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation method thereof and pharmaceutical use thereof Grant 9,994,566 - Zhou , et al. June 12, 2	2018-06-12
Compound Of 5-hydroxyl-1,7-naphthyridine Substituted By Aryloxy Or Heteroaryloxy, Preparation Method Thereof And Pharmaceutical Use Thereof App 20180118739 - ZHOU; Yunlong ; et al.	2018-05-03
Compound Of 5-hydroxyl-1,7-naphthyridine Substituted By Aryl Or Heteroaryl, Preparation Method Thereof And Pharmaceutical Use Thereof App 20180118738 - ZHOU; Yunlong ; et al.	2018-05-03
Compound Of 3-hydroxyl Pyridine, Preparation Method Thereof And Pharmaceutical Use Thereof App 20180117021 - ZHOU; Yunlong ; et al.	2018-05-03
Solid Pharmaceutical Formulation of PARP Inhibitors and Use Thereof App 20180071290 - CAI; Suixiong ; et al.	2018-03-15
3-aryl-6-aryl-[1,2,4]triazolo[4,3-.alpha.]pyridines as inhibitors of cell proliferation and the use thereof Grant 9,199,983 - Cai , et al. December 1, 2	2015-12-01
1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof Grant 9,102,631 - Cai , et al. August 11, 2	2015-08-11
N-(3-heteroarylaryl)-4-arylarylcarboxamides and Analogs as Hedgehog Pathway Inhibitors and Use Thereof App 20150191460 - Cai; Suixiong ; et al.	2015-07-09
1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof App 20140275711 - Cai; Suixiong ; et al.	2014-09-18
3-Aryl-6-aryl-[1,2,4]triazolo[4,3-alpha]pyridines as Inhibitors of Cell Proliferation and the Use Thereof App 20130280245 - Cai; Suixiong ; et al.	2013-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.